Germany - Intermediate Consumption in Protection of Biodiversity and Landscape in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector
Since 2013, Germany Intermediate Consumption in Protection of Biodiversity and Landscape in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector decreased by 61.2% year on year. With €0.1 Million in 2017, the country was ranked number 2 comparing other countries in Intermediate Consumption in Protection of Biodiversity and Landscape in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector. Belgium topped the ranking with €0.4 Million in 2017, that is +33.3% compared to 2016. Belgium witnessed the best average annual growth at +26% per year, while Germany was the worst growing country at -61.2% per year.
Loading...
| Date | Million Euros |
|---|---|
| 2017 | 0.10 |
| 2016 | 0.20 |
| 2015 | 1.60 |
| 2014 | 3.00 |
| 2013 | 4.40 |
Download all data from 2013 to 2017
How does Germany rank in Intermediate Consumption in Protection of Biodiversity and Landscape in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector?
| # | 2 Countries | Million Euros | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Belgium
|
0.40 | 2017 | +33.3 % | +26.0 % | View data |
| 2 |
#2
Germany
|
0.10 | 2017 | -50.0 % | -61.2 % | View data |